4//SEC Filing
ANGIODYNAMICS INC 4
Accession 0001140361-13-043206
$ANGOCIK 0001275187operating
Filed
Nov 14, 7:00 PM ET
Accepted
Nov 15, 5:23 PM ET
Size
10.0 KB
Accession
0001140361-13-043206
Insider Transaction Report
Form 4
Greiner Charles R
VP - Global Franchise
Transactions
- Sale
Common Stock
2013-11-13$15.40/sh−2,392$36,842→ 23,128 total - Exercise/Conversion
Common Stock
2013-11-14$13.18/sh+4,373$57,636→ 27,501 total - Sale
Common Stock
2013-11-14$15.46/sh−4,373$67,611→ 23,128 total - Exercise/Conversion
Non-Qualified Stock Option (right to buy)
2013-11-14−4,373→ 0 totalExercise: $13.18Exp: 2014-07-20→ Common Stock (4,373 underlying)
Footnotes (2)
- [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.4017 to $15.4035, inclusive. The reporting person has provided to AngioDynamics, Inc., and undertakes to provide to any security holder of AngioDynamics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote 1.
- [F2]Options for 25% of the shares became exercisable on 7/20/2005, 7/20/2006, 7/20/2007 and 7/20/2008.
Documents
Issuer
ANGIODYNAMICS INC
CIK 0001275187
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001275187
Filing Metadata
- Form type
- 4
- Filed
- Nov 14, 7:00 PM ET
- Accepted
- Nov 15, 5:23 PM ET
- Size
- 10.0 KB